|
2024
|
Invention
|
[6r]-mthf in b6 enhanced 5-fu based chemotherapy of pancreatic cancer. The present invention rela... |
|
2023
|
Invention
|
[6r]-mthf in b6 enhanced 5-fu based chemotherapy of carcinoma.
The present invention relates to ... |
|
|
Invention
|
[6r]-mthf in b6 enhanced 5-fu based chemotherapy of pancreatic cancer.
The present invention rel... |
|
|
Invention
|
Administration regime.
A method for determining a folate substance administration regime is disc... |
|
2022
|
Invention
|
Methods for treating colorectal and metastatic colorectal cancers.
The present invention provide... |
|
|
Invention
|
[6r]-mthf in 5-fu based chemotherapy of braf- or kras-mutated colorectal cancer. The present inve... |
|
|
P/S
|
Medical, pharmaceutical and biological research services; conducting scientific projects in the n... |
|
2021
|
Invention
|
[6r]-mthf in 5-fu based chemotherapy of right-sided colorectal cancer.
The present invention rel... |
|
|
Invention
|
[6r]-mthf in 5-fu based chemotherapy of left-sided colorectal cancer.
The present invention rela... |
|
|
Invention
|
[6r]-mthf in 5-fu based chemotherapy of braf- or kras-mutated colorectal cancer.
The present inv... |
|
|
Invention
|
[6r]-mthf in 5-fu based chemotherapy of right-sided colorectal cancer. BRAFKRAS KRAS mutations, w... |
|
|
Invention
|
Ras-mutated colorectal cancer. BRAF-KRAS-KRAS-mutations, which involves administering multiple bo... |
|
|
Invention
|
[6r]-mthf in 5-fu based chemotherapy of left-sided colorectal cancer. KRASKRAS-mutated and wild-t... |
|
|
Invention
|
[6r]-mthf - an efficient folate alternative in 5-fluorouracil based chemotherapy.
The present in... |
|
|
P/S
|
Medical, pharmaceutical and biological research services;
conducting scientific projects in the ... |
|
2020
|
P/S
|
Medical, pharmaceutical and biological research services; conducting scientific projects in the f... |
|
|
Invention
|
Methods for increasing blood plasma 2′-deoxyuridine (durd) and thymidylate synthase inhibition. T... |
|
2019
|
Invention
|
Methods for treating colorectal and metastatic colorectal cancers. The present invention provides... |
|
2018
|
P/S
|
Pharmaceutical preparations used for cancer treatment of human patients provided by medical profe... |
|
|
P/S
|
Pharmaceutical preparations used for cancer treatment of
human patients provided by medical prof... |
|
|
Invention
|
Methods for increasing blood plasma 2'-deoxyuridine (durd) and thymidylate synthase inhibition. T... |
|
|
Invention
|
[6r]—mthf—an efficient folate alternative in 5-fluorouracil based chemotherapy. The present inven... |
|
|
Invention
|
(6r)-mthf multiple bolus administration in 5-fluorouracil based chemotherapy. The present inventi... |
|
|
Invention
|
[6r]-mthf-an efficient folate alternative in 5-fluorouracil based chemotherapy. The present inven... |
|
|
Invention
|
[6r]-mthf – an efficient folate alternative in 5-fluorouracil based chemotherapy. The present inv... |
|
|
Invention
|
[6r]-mthf multiple bolus administration in 5-fluorouracil based chemotherapy. The present inventi... |
|
|
Invention
|
[6r]-mthf - an efficient folate alternative in 5-fluorouracil based chemotherapy. The present inv... |
|
2015
|
Invention
|
Reduction of toxicity of multi-targeting antifolates. The use of tetrahydrofolate, methylene-tetr... |
|
|
Invention
|
Administration regime. A method for determining a folate substance administration regime is discl... |
|
2013
|
Invention
|
Tetrahydrofolates in combination with egfr-inhibitors. The present invention relates a pharmaceut... |
|
|
Invention
|
Anti-tumor activity of reduced folates like methylene-tetrahydrofolate.
The present invention re... |
|
|
Invention
|
Anti-tumor activity of reduced folates like methylene-tetrahydrofolate. The present invention rel... |
|
2004
|
Invention
|
Reduction of toxicity of multi-targeting antifolates.
The use of tetrahydrofolate, methylene-tet... |
